Portfolio company
Sedivention
Germany · £2.5m raised
Raised
£2.5m
Latest stage
Seed
Rounds recorded
1
Backed by
1 investor
Sectors
About
This company develops a cryo-balloon catheter to perform nerve ablation for treating obesity in patients via a minimally invasive outpatient procedure.
SourceFunding history · 1
Similar companies
MedVasc
This company develops a catheter for delivering local anaesthesia during endothermal treatment of varicose veins for clinicians and patients.
ValenTx
This company develops a minimally invasive implantable medical device that treats obesity and metabolic disorders by mimicking gastric bypass surgery.
Oxford Medical Products
This company develops self-expanding hydrogel capsules to treat obesity in adults by mechanically inducing satiety and suppressing appetite.
S4 Medical
This company develops an esophageal deviation device to protect patients from thermal injury during cardiac ablation procedures for atrial fibrillation.
CryoTherapeutics SA
This company develops an intravascular cryotherapy catheter system to stabilise high-risk coronary plaques for interventional cardiologists to prevent heart attacks.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Corveus
This company develops a catheter-based medical device for nerve ablation to treat patients suffering from congestive heart failure.
StimCardio
This company develops non-invasive wearable neuromodulation devices for patients with atrial fibrillation to reduce heart arrhythmia recurrence following medical procedures.
